Please wait a minute...
Search Asian J Urol Advanced Search
Share 
Asian Journal of Urology, 2024, 11(3): 460-465    doi: 10.1016/j.ajur.2023.01.001
  本期目录 | 过刊浏览 | 高级检索 |
Comparative study of thulium fiber laser versus holmium:yttrium-aluminum-garnet laser for ureteric stone management with semi-rigid ureteroscopy: A prospective, single-center study
Ankit Gupta*(),Arvind P. Ganpule,Ankush Puri,Abhishek G. Singh,Ravindra B. Sabnis,Mahesh R. Desai
Muljibhai Patel Urological Hospital, Nadiad, Gujarat, India
下载:  HTML  PDF (975KB) 
输出:  BibTeX | EndNote (RIS)      
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
Abstract: 

Objective: To compare the efficacy and safety of thulium fiber laser (TFL) and holmium:yttrium-aluminum-garnet (Ho:YAG) laser for ureteric stone management with semi-rigid ureteroscopy.

Methods: In a prospective study from January 2020 to December 2021, we compared 40 patients in each group who underwent semi-rigid ureteroscopic lithotripsy with TFL and that with Ho:YAG laser. Stone volume, stone density, stone fragmentation rates, total lasing time, total operative time, endoscopic vision, retropulsion and stone free rates were analyzed in both groups and compared.

Results: Mean stone volume was comparable in the TFL group and the Ho:YAG laser group (282.45 [standard deviation, SD 139.79] mm3 vs. 279.49 [SD 312.52] mm3; p=0.964). Mean stone density was also comparable in the TFL group and the Ho:YAG laser group (1135.30 [SD 317.04] Hounsfield unit vs. 1131.75 [SD 283.03] Hounsfield unit; p=0.959). The mean stone fragmentation rates calculated as stone volume divided by lasing time were 25.85 (SD 10.61) mm3/min and 21.37 (SD 14.13) mm3/min in the TFL group and the Ho:YAG laser group, respectively (p=0.113). The mean total lasing time (10.15 [SD] 4.69 min vs. 11.43 [SD 4.56] min; p=0.222), mean operative time (25.13 [SD 9.51] min vs. 25.54 [SD 10.32] min; p=0.866), and mean total hospital stay (2.62 [SD 0.77] days vs. 2.61 [SD 0.84] days; p=0.893) were comparable in the TFL group and in the Ho:YAG group. The vision was better and retropulsion was less in the TFL group. The stone-free rate at 1 month postoperatively was slightly better in the TFL group (100% vs. 90%; p=0.095).

Conclusion: TFL technology was associated with the comparable total surgical time, total lasing time, and stone fragmentation rate with Ho:YAG laser. However, TFL had better endoscopic vision, lesser stone retropulsion, and slightly better stone-free rates.

Key words:  Laser    Stone    Urolithiasis    Thulium    Holmium
收稿日期:  2022-09-02           接受日期:  2023-01-03      出版日期:  2024-07-20      发布日期:  2024-08-13      整期出版日期:  2024-07-20
引用本文:    
. [J]. Asian Journal of Urology, 2024, 11(3): 460-465.
Ankit Gupta, Arvind P. Ganpule, Ankush Puri, Abhishek G. Singh, Ravindra B. Sabnis, Mahesh R. Desai. Comparative study of thulium fiber laser versus holmium:yttrium-aluminum-garnet laser for ureteric stone management with semi-rigid ureteroscopy: A prospective, single-center study. Asian Journal of Urology, 2024, 11(3): 460-465.
链接本文:  
http://www.ajurology.com/CN/10.1016/j.ajur.2023.01.001  或          http://www.ajurology.com/CN/Y2024/V11/I3/460
  
Characteristic TFL Ho:YAG laser p-Value
Agea, year 44.93±14.11 47.72±12.88 0.411
Sex, n (%) 0.742
Male 25 (62.5) 32 (80.0)
Female 15 (37.5) 8 (20.0)
Side, n (%) 0.820
Right 18 (45.0) 16 (40.0)
Left 22 (55.0) 24 (60.0)
Stone location, n (%) 0.687
Mid ureter 24 (60.0) 26 (65.0)
Lower ureter 16 (40.0) 14 (35.0)
Volume of stonea, mm3 282.45±139.79 279.49±312.52 0.964
Stone densitya, HU 1135.30±317.04 1131.75±283.03 0.959
Stone fragmentation ratea, mm3/min 25.85±10.61 21.37±14.13 0.113
Total laser energy consumeda, kJ 6.73±2.75 7.06±3.53 0.674
  
Group Likert scale for grading vision, n (%)
1 (blurred) 2 (hazy) 3 (grainy) 4 (sharp) 5 (excellent)
Ho:YAG laser 1 (2.5) 2 (5.0) 10 (25.0) 6 (15.0) 21 (52.5)
TFL 0 1 (2.5) 5 (12.5) 4 (10.0) 30 (75.0)
  
Group Likert scale for grading stone retropulsion, n (%)
0 (no retropulsion) 1 (mild retropulsion but allowed easy lasing) 2 (severe retropulsion which made lasing difficult)
Ho:YAG laser 25 (62.5) 10 (25.0) 5 (12.5)
TFL 37 (92.5) 3 (7.5) 0
  
[1] Terry RS, Whelan PS, Lipkin ME. New devices for kidney stone management. Curr Opin Urol 2020; 30:144-8.
[2] Noureldin YA, Kallidonis P, Liatsikos EN. Lasers for stone treatment: how safe are they? Curr Opin Urol 2020; 30:130-4.
[3] Ibrahim A, Elhilali MM, Fahmy N, Carrier S, Andonian S. Double- blinded prospective randomized clinical trial comparing regular and Moses modes of holmium laser lithotripsy. J Endourol 2020; 34:624-8.
[4] Andreeva V, Vinarov A, Yaroslavsky I, Kovalenko A, Vybornov A, Rapoport L, et al. Preclinical comparison of super pulse thulium fiber laser and holmium:YAG laser for lithotripsy. World J Urol 2020; 38:497-503.
[5] Martov AG, Ergakov DV, Guseinov MA, Andronov AS, Dutov SV, Vinnichenko VA, et al. [Initial experience in the clinical application of thulium laser contact lithotripsy for transurethral treatment of urolithiasis]. Urologiia 2018; 112-20. [Article in Russian]. PMID: 29634144.
[6] Hardy LA, Vinnichenko V, Fried NM. High power holmium:YAG versus thulium fiber laser treatment of kidney stones in dusting mode: ablation rate and fragment size studies. Laser Surg Med 2019; 51:522-30.
[7] Dupont WD, Plummer WD Jr. Power and sample size calculations: a review and computer program. Contr Clin Trials 1990; 11:116-28.
[8] Fried NM. Thulium fiber laser lithotripsy: an in vitro analysis of stone fragmentation using a modulated 110 W thulium fiber laser at 1.94 microm. Laser Surg Med 2005; 37:53-8.
[9] Scott NJ, Cilip CM, Fried NM. Thulium fiber laser ablation of urinary stones through small-core optical fibers. IEEE J Sel Top Quant 2009; 15:435-40.
[10] Kronenberg P, Traxer O. The laser of the future: reality and expectations about the new thulium fiber laserda systematic review. Transl Androl Urol 2019 ;8(Suppl 4):S398-417. https://doi.org/10.21037/tau.2019.08.01
doi: https://doi.org/10.21037/tau.2019.08.01
[11] Sandhu AS, Srivastava A, Madhusoodanan P, Sinha T, Gupta SK, Kumar A, et al. Holmium:YAG laser for intra corporeal lithotripsy. Med J Armed Forces India 2007; 63:48-51.
[12] De Coninck V, Keller EX, Somani B, Giusti G, Proietti S, Rodriguez-Socarras M, et al. Complications of ureteroscopy: a complete overview. World J Urol 2020; 38:2147-66.
[13] Martov AG, Ergakov DV, Guseynov M, Andronov AS, Plekhanova OA. Clinical comparison of super pulse thulium fiber laser and high-power holmium laser for ureteral stone management. J Endourol 2021; 35:795-800.
[14] Hardy LA, Irby PB, Fried NM. Scanning electron microscopy of real and artificial kidney stones before and after thulium fiber laser ablation in air and water. Proc SPIE 2018; 10468:104680G. https://doi.org/10.1117/12.2285069
doi: https://doi.org/10.1117/12.2285069
[15] Matlaga BR, Chew B, Eisner B, Humphreys M, Knudsen B, Krambeck A, et al. Ureteroscopic laser lithotripsy: a review of dusting vs. fragmentation with extraction. J Endourol 2018; 32:1-6.
[16] Panthier F, Doizi S, Corrales M, Traxer O. Pulsed lasers and endocorporeal laser lithotripsy. Prog Urol 2021; 31:451-7.
[17] Traxer O, Keller EX. Thulium fiber laser: the new player for kidney stone treatment? A comparison with holmium:YAG laser. World J Urol 2020; 38:1883-94.
[18] Blackmon RL, Irby PB, Fried NM. Holmium:YAG (lZ2120 nm) versus thulium fiber (lZ1908 nm) laser lithotripsy. Laser Surg Med 2021; 42:232-6.
[19] Kronenberg P, Hameed BZ, Somani B. Outcomes of thulium fiber laser for treatment of urinary tract stones: results of a systematic review. Curr Opin Urol 2021; 31:80-6.
[20] Hardy LA, Wilson CR, Irby PB, Fried NM. Thulium fiber laser lithotripsy in an in vitro ureter model. J Biomed Opt 2014; 19:128001. https://doi.org/10.1117/1.JBO.19.12.128001
doi: https://doi.org/10.1117/1.JBO.19.12.128001
[21] Mahajan AD, Mahajan SA. Thulium fiber laser versus holmium: yttrium aluminum garnet laser for stone lithotripsy during mini-percutaneous nephrolithotomy: a prospective randomized trial. Indian J Urol 2022; 38:42-7.
No related articles found!
[1] Brian W. Chao, Daniel D. Eun. Robotic reconstructive surgery: The time has arrived[J]. Asian Journal of Urology, 2024, 11(3): 339 -340 .
[2] Yogender S. Kadian, Mahavir Singh, Kamal N. Rattan. The role of tunica vaginalis flap in staged repair of hypospadias[J]. Asian Journal of Urology, 2017, 4(2): 107 -110 .
[3] Ponco Birowo,Nur Rasyid,Chaidir A. Mochtar,Bambang S. Noegroho,H.R. Danarto,Besut Daryanto,Lukman Hakim,Dyandra Parikesit,Fakhri Rahman,S. Cahyo Ariwicaksono. Daily activities and training experiences of urology residents during the coronavirus disease 2019 pandemic in Indonesia: A nationwide survey[J]. Asian Journal of Urology, 2023, 10(2): 119 -127 .
[4] Varma Hegde Abheesh,Choubey Suryakanth,Siddappa Kanagali Revanna,Pipara Gotam,Rao A.Nagaraja,Mohan A.. Listening to his inner voice? An unusual urethral foreign body: A review of literature and few learning points[J]. Asian Journal of Urology, 2018, 5(2): 131 -132 .
[5] Hamed Ahmadi,Thomas L. Jang,Siamak Daneshmand,Saum Ghodoussipour. Editorial by Bendu K. Konneh, John T. Lafin and Aditya Bagrodia on pp. 341-342 of this issue: MicroRNA-371a-3p as a blood-based biomarker in testis cancer[J]. Asian Journal of Urology, 2021, 8(4): 400 -406 .
[6] Nora Naqos,Wafaa Kaikani. Prostate cancer—highlights from American Society of Clinical Oncology virtual meeting 2020[J]. Asian Journal of Urology, 2022, 9(3): 282 -286 .
[7] Eric Chung. A review of regenerative therapies as penile rehabilitation in men following primary prostate cancer treatment: Evidence for erectile restoration and cavernous nerve regeneration[J]. Asian Journal of Urology, 2022, 9(3): 287 -293 .
[8] Biagio Barone,Luigi De Luca,Luigi Napolitano,Vincenzo Francesco Caputo,Mariano Marsicano,Gennaro Cancelmo,Massimiliano Creta,Ferdinando Fusco. Bilateral calcified Macroplastique® after 12 years[J]. Asian Journal of Urology, 2022, 9(3): 334 -336 .
[9] Hiroshi Hongo,Takeo Kosaka,Kohei Nakamura,Shuji Mikami,Hiroshi Nishihara,Mototsugu Oya. The first Japanese case of intraductal cancer of the prostate with checkpoint kinase 2 mutation[J]. Asian Journal of Urology, 2022, 9(4): 480 -482 .
[10] Victor Chalfant,Michael L. BluteJr.,Peter Silberstein. Treatment trends of muscle invasive bladder cancer: Evidence from the Surveillance, Epidemiology, and End Results database, 1988 to 2013[J]. Asian Journal of Urology, 2023, 10(1): 9 -18 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed